Jamieson Bondarenko is Chairman of BriaCell Therapeutics Corp.. Currently has a direct ownership of 169,856 shares of BCTX, which is worth approximately $67,942. The most recent transaction as insider was on Dec 28, 2022, when has been sold 28,000 shares (Common Shares) at a price of $4.58 per share, resulting in proceeds of $128,240. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 170K
0% 3M change
0% 12M change
Total Value Held $67,942

Jamieson Bondarenko Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 28 2022
BUY
Open market or private purchase
$128,240 $4.58 p/Share
28,000 Added 14.15%
169,856 Common Shares
Dec 20 2022
BUY
Open market or private purchase
$117,699 $5.35 p/Share
22,000 Added 13.43%
141,856 Common Shares
JB

Jamieson Bondarenko

Chairman
West Vancouver, A1

Track Institutional and Insider Activities on BCTX

Follow BriaCell Therapeutics Corp. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BCTX shares.

Notify only if

Insider Trading

Get notified when an Bria Cell Therapeutics Corp. insider buys or sells BCTX shares.

Notify only if

News

Receive news related to BriaCell Therapeutics Corp.

Track Activities on BCTX